Physician

Abraham S Salacata, M.D.

According to 2025 Medicare claims, Abraham Salacata, M.D. (NPI: 1255440095) practices cardiology in the Bay City, MI market, with the plurality of this provider's patient population coming from Bay, MI. This provider's primary affiliated billing organization is MCLAREN BAY REGION (NPI: 1508131087; TIN: 381976271) and primary practice location at 48708-6831. Salacata is affiliated with the POM ACO (ACO ID: A1297), McLaren High Performance Network, LLC (ACO ID: A3317), and Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Salacata's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,208 traditional Medicare patients, billed 3,987 HCPCS/CPT codes, and received $185,174 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 1,067 prescription claims across 207 beneficiaries totaling $2,145,522 in drug costs, led by Adempas (Riociguat). 2020 DME data shows 12 claims. Open Payments data shows 18 records totaling $348. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $339,782 and ending at $185,174. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $244,594 to $2,145,522. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $4,696 to $137.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,591	7,096	$339,782
2016	1,498	5,885	$184,972
2017	1,506	5,250	$175,903
2018	1,319	3,598	$135,948
2019	2,028	5,185	$161,518
2020	1,559	4,102	$131,327
2021	3,698	7,124	$201,910
2022	1,056	1,910	$84,366
2023	1,232	3,358	$142,733
2024	1,208	3,987	$185,174

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	381	2,615	$244,594
2016	471	3,241	$389,560
2017	526	3,704	$542,185
2018	549	3,571	$464,762
2019	510	3,131	$435,336
2020	521	3,707	$587,891
2021	461	2,385	$490,074
2022	139	494	$1,092,648
2023	164	716	$1,740,213
2024	207	1,067	$2,145,522

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	21	$2,979
2016	N/R	35	$2,510
2017	N/R	45	$1,839
2018	N/R	31	$1,757
2019	N/R	11	$109
2020	N/R	12	$90
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	170	185	$104
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	261	530	$64
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	306	327	$55
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	314	682	$22
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	171	265	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Adempas	Riociguat	51	1,530	$710,923
Opsumit	Macitentan	55	1,650	$679,938
Uptravi	Selexipag	11	330	$165,327
Eliquis	Apixaban	107	6,270	$117,778
Entresto	Sacubitril/Valsartan	35	2,315	$50,031

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$348	Actelion Pharmaceuticals US, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abraham S. Salacata, M.D.?

Tedicare shows public-source Medicare data for Abraham S. Salacata, M.D. (NPI 1255440095), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abraham S. Salacata, M.D. have ACO affiliation data?

Abraham S. Salacata, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), McLaren High Performance Network, LLC (MSSP, ACO ID A3317), and Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Abraham S. Salacata, M.D.?

Abraham S. Salacata, M.D. is linked to MCLAREN BAY REGION (billing NPI 1508131087) in the available physician profile data.

Does Abraham S. Salacata, M.D. have Open Payments data?

Abraham S. Salacata, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.